Insights+ Key Biosimilars Events of April 2024
Shots: Biosimilars are developed to be highly similar vers...
Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)
Shots: Witness the journey of the biopharma companies over 20 ye...
New Drug Designations - March 2024
Shots: PharmaShots' designation report provides a concise overview...
Know Your Investor (April Edition): OrbiMed Advisors
Shots: An American investment firm, OrbiMed Advisor is a prominent name when it co...
Insights+: EMA Marketing Authorization of New Drugs in March 2024
Shots: The EC approved 1 Biologic and 11 New Chemical Entities in March 2024, leading t...
Disease of the Month - Duchenne Muscular Dystrophy (DMD)
Shots: The Disease of the Month report by PharmaShots aims to integrat...
